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Abstract
Obesity and obesity-associated diseases e.g. cardiovascular diseases and type 2 diabetes are spread worldwide.
Anthocyanins are supposed to have health-promoting properties, although convincing evidence is lacking. The aim of the
present study was to investigate the effect of anthocyanins on several risk factors for obesity-associated diseases. Therefore,
Fischer rats were fed anthocyanin-rich grape-bilberry juice or an anthocyanin-depleted control juice for 10 weeks.
Intervention with anthocyanin-rich grape-bilberry juice reduced serum cholesterol and tended to decrease serum
triglycerides. No effects were seen for serum non-esterified fatty acids, glucose, and insulin. Anthocyanin-rich grape-bilberry
juice intervention reduced serum leptin and resistin, but showed no influence on serum adiponectin and secretion of
adipokines from mesenteric adipose tissue. Furthermore, anthocyanin-rich grape-bilberry juice increased the proportion of
polyunsaturated fatty acids and decreased the amount of saturated fatty acids in plasma. These results indicate that
anthocyanins possess a preventive potential for obesity-associated diseases.
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Introduction
In Western countries with high prevalence of obesity and its
associated diseases, cardiovascular diseases and diabetes are severe
public health problems. As obesity is spreading worldwide, it is
expected that the incidence of these diseases will increase over the
coming years [1].
Anthocyanins, a subgroup of flavonoids, occur in red, violet,
and blue fruits and vegetables, especially berries. Several health-
promoting properties are discussed for anthocyanins, including
anti-diabetic properties and beneficial effects on the cardiovascular
system [2]. Two rodent and one human study could show glucose
and/or insulin-lowering effects of anthocyanins [3–5]. Data on the
effects of anthocyanins on cholesterol and triglyceride levels, which
are risk factors for cardiovascular diseases, are rather inconsistent.
In several human and animal studies cholesterol and/or triglyc-
eride-lowering effects occurred, while other studies showed no
influence [6–9] and in one animal study the anthocyanin
intervention even increased serum triglycerides and cholesterol
[10].
The development of cardiovascular diseases, particularly
atherosclerosis, is associated with endothelial dysfunction. Satu-
rated fatty acids (SFA) are known to impair, whereas long-chain
n3-polyunsaturated fatty acids (PUFA) improve endothelial
function [11]. So far only one intervention study investigated the
influence of anthocyanins on plasma fatty acid composition using a
background diet with low fat content (10%), but high in PUFA.
Supplementing this diet with anthocyanins increased the amount
of the long-chain n-3-PUFA EPA and DHA in plasma of rats [12].
Furthermore, it has been reported, that EPA and DHA
concentrations are increased in humans with regular wine
consumption, regardless of the wine color [13].
The adipose tissue secretes several mediators, called adipokines
(e.g. adiponectin, leptin, and resistin), which have regulatory
functions in the metabolism. Additionally, it has been reported
that adipokines are involved in the development of metabolic
diseases, such as type 2 diabetes and cardiovascular diseases. High
levels of leptin and resistin, occurring in obese individuals,
promote the development of insulin resistance, whereas adipo-
nectin seems to prevent insulin resistance [14]. For a detailed
description of the effects of adipokines the reader is referred to the
review of Ouchi et al. [14]. The human visceral adipose tissue
seems to be important in the development of obesity-associated
diseases, especially diabetes. Because of the portal drainage, only
the mesenteric adipose tissue (MAT) in rodents resembles human
visceral adipose tissue [15]. So far, it is unknown how anthocy-
anins affect the secretory properties of MAT.
The aim of the present study was to investigate the effect of a
10-week intervention with anthocyanins on several risk factors for
diabetes and cardiovascular diseases, as well as on plasma fatty
acid composition. One focus of the present study was to mimic the
situation in Western countries. Therefore, we used a diet which
ensured a Western-style fat intake and focussed on MAT as fat
depot. Fischer rats were fed a diet containing 34% energy from fat
with high content of SFA, which closely resembles fat intake in
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Western countries, and received an anthocyanin-rich grape-
bilberry juice (ARJ).
Materials and Methods
Ethics statement
This study was approved by the Animal Care Committee of the
Regional Administrative Authority Karlsruhe (Permit Number:
35-9185.81/G-221/10) and all animal care and handling were
conducted in strict accordance with the guidelines of the German
law on animal care.
Animals and diets
Male Fischer 344 rats at the age of 10 weeks were purchased
from Charles River Laboratories (Sulzfeld, Germany). Rats were
housed two animals per cage under temperature- (2162uC) and
humidity-controlled (55–65%) conditions with a 12-h-light/-dark
cycle. After one week of adaption animals were randomly assigned
to intervention groups (n = 30/group). Blood and organs from six
animals per group were used to assess bioavailability of
anthocyanins. The anthocyanin group received ARJ, containing
1551 mg anthocyanins/L, the control group received polyphenol-
depleted grape-bilberry juice. Pure juices were the only sources of
liquids. The major anthocyanins were malvidin-3,5-diglucoside
and peonidin-3,5-diglucoside. The composition of the juices and
data of anthocyanin analysis has been described in detail elsewhere
[16]. Juices were produced by the Geisenheim Research Centre.
The juices were provided daily via the drinking bottle, right before
the beginning of the 12-h-dark cycle, in order to ensure maximum
light protection of anthocyanins. The daily juice consumption was
recorded. Rats were fed a diet based on AIN93G containing 17%
(wt:wt) lard (Ssniff, Soest, Germany), accounting for 34% energy.
Due to its fatty acid composition with high SFA and low PUFA,
lard was chosen as fat source. Rats received diet and juice ad
libitum. Body weight and food intake were recorded four times a
week. After 8 weeks of intervention, rats of the bioavailability
group were housed individually in metabolism cages for 24 h, to
collect urine and feces. After 10 weeks of intervention, rats were
feed-deprived overnight, anesthetized by exposure to CO2, and
killed by decapitation. Blood was collected and processed for
serum and plasma. The mesenteries were collected and mesenteric
adipose tissue (MAT) was isolated. Livers were frozen immediately
on dry ice and stored at 280uC until further analysis.
Sample preparation
Short term culture of MAT specimens. For measuring the
adipokine release of MAT the method of Paul et al. [17] was used
with slight modifications. Briefly, the mesenteric lymph nodes,
blood vessels, and soft tissue were removed, and adipose tissue
fragments were prepared under sterile conditions. 200–240 mg of
adipose tissue fragments were incubated at 37uC and 5% CO2 in
2 mL DMEM F12 (Invitrogen, Darmstadt, Germany) supple-
mented with 100 mL/L heat-inactivated fetal bovine serum (PAA,
Co¨lbe, Germany), 2 mmol/L L-glutamine, 500 U/L penicillin,
and 50 mg/L streptomycin (all Invitrogen). After 3 h of incubation,
supernatants were collected and stored at 220uC until measure-
ment of adipokines. For each rat, sample preparation was
accomplished in triplicate.
Preparation of serum. For serum preparation blood was
collected and the clotted blood was centrifuged at 2000 x g for
10 min. Aliquots of serum were stored at 220uC until further
analysis.
Preparation of plasma. For plasma preparation blood was
collected in heparinised tubes and centrifuged at 400 x g for
10 min. 0.1 mg BHT/mL plasma was added and aliquots were
stored at 220uC until further analysis.
Quantification of adipokines
For the quantification of adiponectin (AdipoGen, Liestal,
Switzerland), leptin, and resistin (BioVendor, Heidelberg, Ger-
many) in tissue culture supernatant or serum, sandwich ELISAs
were performed according to the manufacturer’s instructions. For
quantification of adipokines in MAT supernatant, the triplicates
were pooled and analysed in duplicates.
Measurement of glucose, insulin, cholesterol, non-
esterified fatty acids (NEFA), and triglycerides in serum
Glucose (Gluco-Quant, Roche, Mannheim, Germany), insulin
(Rat insulin ELISA, Millipore, Schwalbach, Germany), cholesterol
(CHOD-PAP, Roche), NEFA (NEFA-HR2, Wako, Neuss, Ger-
many), and triglycerides (GPO-PAP, Roche) were measured using
commercial kits according to the manufacturers’ instructions.
Measurement of fatty acid profiles in plasma
For analysis of plasma fatty acids a GC method with flame
ionization detection was used, which separated FAME ranging
from C4 to C26. The detailed method was described earlier [18].
Statistical analysis
For statistical analysis of effects between the two groups t-tests
were performed. If data failed to satisfy variance homogeneity or
normal distribution, the Mann-Whitney Rank Sum test was
employed. SigmaPlot 11.0 (Systat Software, Erkrath, Germany)
was used for all statistical analyses. Differences were considered
statistically significant when p , 0.05. All data are presented as
mean 6 standard deviation.
Results
Body weight and food consumption
Data on food, juice, and anthocyanin intake as well as body and
organ weights have been presented previously [16]. In brief,
neither food and juice intake, nor body and organ weights differed
between the groups. Anthocyanin intake in the ARJ group was
15 mg anthocyanins/day, which corresponds to approximately
50 mg/kg body weight, whereas anthocyanin intake of the control
group was less than 0.01 mg/day.
Glucose, insulin, cholesterol, NEFA, and triglycerides in
serum
The intervention with ARJ did not influence serum glucose and
insulin levels (Table 1). Cholesterol concentrations were reduced
after 10 weeks of ARJ consumption (Table 1). ARJ also tended to
decrease triglyceride concentrations (p = 0.08). Serum NEFA levels
were not influenced by the intervention with ARJ (Table 1).
Adipokines in serum and MAT culture supernatant
The adipokines adiponectin, leptin, and resistin were quantified
in serum and MAT culture supernatant. Rats of the ARJ group
had lower serum leptin and resistin levels compared to the control
group. Adiponectin serum levels did not differ between ARJ and
control group (Figure 1).
The intervention did not influence the adipokine concentrations
in tissue culture supernatants of MAT (Table 2).
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Fatty acids in plasma
The distribution of fatty acids was determined in plasma
(Table 3). As shown in Figure 2, the treatment with ARJ lowered
the percentage of SFA and enhanced PUFA in plasma. The
reduced SFA are mainly due to a decrease in palmitic acid (C16:0),
whereas for PUFA the highest increases were seen for arachidonic
(C20:4n-6) and linoleic acid (C18:2n-6). Nonetheless, the n-6/n-3-
ratio did not differ between ARJ and control group, since several
n-3 PUFA increased, too.
Discussion
In the present study, the influence of an ARJ intervention on
carbohydrate and lipid metabolism, serum concentrations and
MAT secretion of adipokines, and fatty acid profil in plasma was
investigated. As we intended to determine the preventive potential
of an anthocyanin-rich diet, we decided to use a whole food in
form of a juice and not to use supplements for this intervention.
Rats of the anthocyanin group ingested approximately 15 mg total
anthocyanins per day, which corresponds to 50 mg/kg body
weight. As discussed in Graf et al. [16], this can rather be seen as a
physiological and not pharmacological dose, which led to plasma
anthocyanin concentrations in the low nanomolar range. Further
bioavailability data are presented elsewhere [16].
For anthocyanins anti-diabetic properties are assumed and
human as well as animal studies reported increased insulin
sensitivity or lower blood glucose concentrations after an
anthocyanin intervention [3–5]. In contrast to these findings,
serum glucose and insulin concentrations were not influenced by
the intervention in the present study. Although rats had free access
to juice until the section, which normally results in higher glucose
and insulin concentration compared to fasting rats, serum glucose
levels were rather low in both groups (1.4 g/L) compared to the
reference values for age-matched Fischer rats (0.9–3.6 g/L with an
average of 2.2 g/L; given by Charles River). Therefore, it seems
consequential that in the present study no direct effects of
anthocyanins on glucose and insulin concentrations in serum were
observed.
Dyslipidemia, especially elevated cholesterol and triglyceride
levels, is a risk factor for cardiovascular diseases [19]. Data on the
impact of anthocyanins on cholesterol and triglyceride levels are
inconsistent [6–10]. Our results indicate that consumption of ARJ
can decrease serum concentrations of cholesterol and triglycerides.
Cholesterol concentrations are influenced by many factors:
intestinal cholesterol absorption, hepatic cholesterol syntheses,
biliary excretion, and cellular use [20]. One possible mechanism
for cholesterol lowering effects of anthocyanins could be the
inhibition of cholesterol synthesis. It has been shown that
anthocyanins can activate AMPK [5,21], which is involved in
the regulation of energy homeostasis and influences the activity of
Table 1. Concentrations of glucose, insulin, cholesterol,
NEFA, and triglycerides in serum of Fischer rats after 10 weeks
of intervention with polyphenol-depleted grape-bilberry juice
(control) or ARJ (n = 24/group).
Control ARJ p-value
Glucose g/L 1.460.1 1.460.2 0.253
Insulin mg/L 2.961.6 3.662.5 0.464
Cholesterol g/L 1.160.1 1.060.1 0.029
NEFA mmol/L 0.6560.21 0.6760.17 0.614
Triglycerides g/L 3.461.0 2.960.8 0.079
ARJ: Anthocyanin-rich grape-bilberry juice
doi:10.1371/journal.pone.0066690.t001
Figure 1. Serum adipokine concentrations. Concentration of
adiponectin, leptin, and resistin in serum of Fischer rats after 10 weeks
of intervention with control juice (white bars) or ARJ (grey bars; n = 24/
group).
doi:10.1371/journal.pone.0066690.g001
Table 2. Concentrations of the adipokines adiponectin,
leptin, and resistin in tissue culture supernatants of MAT of
Fischer rats after 10 weeks of intervention with polyphenol-
depleted grape-bilberry juice (control) or ARJ (n = 24/group).
Control ARJ p-value
Adiponectin 3.760.6 3.960.6 0.21
Leptin 26.965.0 25.565.2 0.36
Resistin 13.264.0 13.162.8 0.78
ARJ: Anthocyanin-rich grape-bilberry juice
doi:10.1371/journal.pone.0066690.t002
Table 3. Major fatty acids1 [% FAME] in plasma of Fischer rats
after 10 weeks of intervention with polyphenol-depleted
grape-bilberry juice (control) or ARJ (n = 24/group).
Control ARJ p-value
C14:0 0.7060.17 0.5160.07 ,0.001
C16:0 23.7462.27 21.9861.63 0.003
C16:1c9 3.1260.88 2.1860.51 ,0.001
C18:0 9.0862.07 9.5461.89 0.529
C18:1c9 25.9863.69 25.6463.02 0.975
C18:1c11 3.0160.34 2.6360.34 ,0.001
C18:2n-6 7.3061.07 8.1960.97 0.004
C20:4n-6 15.7863.28 16.8662.43 0.201
C22:4n-6 0.5760.09 0.6260.10 0.039
C22:5n-6 0.7660.14 0.8360.16 0.062
C22:5n-3 0.4560,13 0.6160.31 0.101
C22:6n-3 0.9560.27 1.0360.22 0.089
n-6/n-3 12/1 12/1 0.990
ARJ: Anthocyanin-rich grape-bilberry juice
1.0.5% FAME
doi:10.1371/journal.pone.0066690.t003
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many enzymes. One enzyme, which is inhibited by AMPK, is
HMG-CoA reductase [22]. As HMG-CoA reductase is the
limiting enzyme of cholesterol synthesis, increased AMPK activity
would inhibit cholesterol synthesis and consequently lead to lower
cholesterol levels. Furthermore, AMPK inhibits the activity of
acetyl-coA carboxylase (ACC) 1 and ACC-2, which leads to
increased fatty acid oxidation and decreased fatty acid synthesis
[22], and, accordingly, lower triglyceride concentrations. Guo et al.
[21] could show an increased AMPK activity which led to
decreased ACC activity and increased fatty acid oxidation in vitro
after incubating HepG2 cells with cyanidin-3-O-b-glucoside. In
light of this, it seems possible that cholesterol and triglyceride
lowering effects of anthocyanins in vivo are mediated via activation
of AMPK. Therefore, future studies should investigate effects of
anthocyanins on AMPK expression and activity.
We further examined the influence of ARJ consumption on fatty
acids in plasma. Although the diet was rich in SFA, SFA decreased
and PUFA increased in plasma after 10 weeks of ARJ
consumption. It has been described by another study that
anthocyanin interventions can increase the plasma concentrations
of the long chain n-3-PUFA EPA (C20:5n-3) and DHA (C22:6n-3)
[12]. Both studies differed in many details, but both indicate that
anthocyanins can increase PUFA concentrations in plasma.
Several beneficial effects of both n-3 and n-6 PUFA have been
described. As PUFA are incorporated in cell membranes, they
influence the membrane fluidity [23], and might therefore have a
positive influence on vascular function [24,25]. Our results might
be a cautious indication that anthocyanins mediate cardioprotec-
tive properties through their influence on plasma fatty acid
composition. Consequently, future studies should also investigate
the influence of anthocyanins on functional membrane fatty acids.
Additionally, it is postulated that PUFA have anti-inflammatory
effects [26]. Our results suggest that anthocyanins might lead to an
altered fatty acid profile with reduced inflammatory potential. As
low grade chronic inflammation is involved in the pathogenesis of
most obesity-associated diseases, these anthocyanin-related effects
on plasma fatty acids should be further investigated.
The intervention with ARJ resulted in reduced serum concen-
trations of leptin and resistin, whereas no effect was observed for
adiponectin. Data on the influence of anthocyanins on adipokines
are rather controversial. In vivo studies with anthocyanins have
reported increased, lowered, as well as unchanged adiponectin
concentrations [6,8,27,28]. For leptin, both, a lowering effect or
no effects have been described [28,10]. Due to the fact that sources
of anthocyanins, background diets, and populations vary in these
studies, it is impossible to identify the causes for the different
outcomes.
Leptin as well as resistin are elevated in obesity [29–31]. It has
been reported that resistin is involved in the pathogenesis of
obesity-associated insulin resistance [32–34]. Consequently, the
reduced resistin concentration after ARJ consumption might
contribute to a lower risk for the development of diabetes.
In contrast to serum concentrations of adipokines, no effect was
observed for the secretory activity of MAT regarding adiponectin,
leptin, and resistin. Guo et al. [27] reported increased gene
expression of adiponectin in epididymal adipose tissue of mice
after intervention with cyanidin-3-glucoside. So far, no study
analysed the secretory activity or gene expression in MAT. In
contrast to other adipose tissues, MAT drains into the portal vein
[35]. Therefore, rodent MAT can be considered as a suitable
model for human visceral adipose tissue, which seems to be
involved in the development of obesity-associated diseases in
humans [36,37]. As different adipose tissues vary in their
endocrine functions, further studies should investigate the secre-
tory activity of various adipose tissues.
Our results indicate a positive influence of anthocyanins on
serum adipokines, which seems to be independent of MAT, the
central visceral adipose tissue. Further studies are needed to
determine which adipose depots are responsible for the observed
changes in serum and under which conditions anthocyanins exert
this effect.
In conclusion, a 10 week intervention with ARJ and a diet,
which mimicked Western fat intake led to changes in plasma fatty
acids as well as to reductions in serum cholesterol, leptin, and
resistin concentrations. These results indicate that intake of
anthocyanins at physiological doses e.g. via complex foods like
juices, might have a preventive potential for obesity-associated
diseases such as cardiovascular disease or type 2 diabetes.
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